Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
about
CarbapenemsComparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.Ertapenem: review of a new carbapenem.In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Complicated urinary tract infection in adults.Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritisUrinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department.Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem.Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.Ertapenem-associated seizures in a peritoneal dialysis patient.Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing
P2860
Q28286055-286194DA-CCE0-48DE-8879-FF2735E74294Q33291234-5B0E8D94-CF64-4F98-94FC-35558D7EC226Q34026343-9EA96070-DB64-4D05-9688-6C60578A9AC8Q35928948-01671F40-8999-4BA7-8476-A7E90A47FE98Q36066200-B038973A-88B3-4AFF-9230-838C5EBDFCF0Q36086360-DECDA66B-B33E-4ED5-937D-859A60372C73Q36170941-9D94AF99-AAF5-4AB8-A510-CBC3B5711D65Q36719706-7D15C7DF-1A86-4ADF-9A5F-78D0CD24A620Q37333147-5C4A091B-AB3E-49E3-9D5B-CF6AD0F96415Q37351384-1CAE39F9-8534-471E-88DA-90A8C02F02E2Q37412959-FDEF952F-3011-421A-B904-9D0E4E2AA297Q37568571-D353406A-F1ED-400F-8A85-3A836AD3B163Q39726288-31DB01FC-EB2F-45A0-B211-62D2D3FE97C8Q44236347-C5B80A17-ADB6-438D-A476-39A23226AB7DQ45219997-464FC7EB-AF2E-4825-A630-756486A8CA5FQ57123140-494B19FA-D7BE-414E-8324-7F0840A65F94
P2860
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@ast
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@en
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@nl
type
label
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@ast
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@en
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@nl
prefLabel
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@ast
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@en
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@nl
P2093
P2860
P1476
Ertapenem versus ceftriaxone f ...... ouble-blind multicenter study.
@en
P2093
Gail L Woods
Kevin M Tomera
Oscar G Pamo Reyna
Protocol 014 Study Group
Richard M Gesser
Wendy M Wimmer
P2860
P304
P356
10.1128/AAC.46.9.2895-2900.2002
P407
P577
2002-09-01T00:00:00Z